THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW.
Al Mushref, Mazen
THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW. [electronic resource] - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists Jan 2020 - 36-42 p. digital
Publication Type: Journal Article
1530-891X
10.4158/EP-2019-0244 doi
Humans
Melanoma
Nivolumab
Prognosis
Retrospective Studies
THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW. [electronic resource] - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists Jan 2020 - 36-42 p. digital
Publication Type: Journal Article
1530-891X
10.4158/EP-2019-0244 doi
Humans
Melanoma
Nivolumab
Prognosis
Retrospective Studies